XML 30 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Feb. 23, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Registrant Name Stoke Therapeutics, Inc.    
Entity Central Index Key 0001623526    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Interactive Data Current Yes    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Well Known Seasoned Issuer No    
Entity Public Float     $ 297
Entity Common Stock, Shares Outstanding   44,147,687  
Entity Shell Company false    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity File Number 001-38938    
Entity Incorporation State Country Code DE    
Entity Tax Identification Number 47-1144582    
Entity Address, Address Line One 45 Wiggins Ave    
Entity Address City Or Town Bedford    
Entity Address State Or Province MA    
Entity Address Postal Zip Code 01730    
City Area Code 781    
Local Phone Number 430-8200    
Document Annual Report true    
Document Transition Report false    
ICFR Auditor Attestation Flag false    
Auditor Firm ID 185    
Auditor Name KPMG LLP    
Auditor Location Boston, MA USA    
Title of 12(b) Security Common Stock, $0.0001 par value per share    
Trading Symbol STOK    
Security Exchange Name NASDAQ    
Documents Incorporated by Reference

Portions of the registrant’s Definitive Proxy Statement relating to the 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein. The Definitive Proxy Statement will be filed within 120 days of the Registrant’s fiscal year ended December 31, 2022. Except with respect to information specifically incorporated by reference in this Form 10-K, the Definitive Proxy Statement is not deemed to be filed as part of this Form 10-K.

Auditor Firm Id:185Auditor Name:KPMG LLPAuditor Location:Boston, MA USA